First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial. - Hainsworth JD; Litchy S; Lamb MR; Rodriguez GI; Scroggin C Jr; Greco FA (Clinical lymphoma, 2003)